Model numbers and product codes play a vital role in driving innovation. They enable:
Employing metaphors, similes, allusions, and other literary devices can add depth and emotion to your text. JUQ-578
| Compound | Target | Development Stage | Distinguishing Feature | |----------|--------|-------------------|------------------------| | | NLRP3 (ATP pocket) | Phase I (suspended) | First‑in‑class, but limited BBB penetration. | | Dapansutrile (OLT1177) | NLRP3 (allosteric) | Phase II (gout) | Orally active, but modest potency (IC₅₀ ≈ 300 nM). | | Tranilast | NLRP3 (indirect) | Repurposed (clinical trials) | Anti‑fibrotic, but off‑target toxicity at high dose. | | JUQ‑578 | NLRP3 (allosteric ATP pocket) | Phase I (2026) | Highest potency, BBB penetration, dual CNS/peripheral indication. | Model numbers and product codes play a vital
Because chronic activation of NLRP3 contributes to neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease) and to systemic inflammatory conditions (type‑2 diabetes, gout), JUJ‑578 is being positioned as a for both central nervous system (CNS) and peripheral indications. | | Dapansutrile (OLT1177) | NLRP3 (allosteric) |